Artrya Limited announced that it has appointed Mr. Mathew Regan as Chief Executive Officer after the resignation of Managing Director and co-founder Mr. John Barrington AM. Mr. Barrington, and the Artrya Board agreed that the Company would benefit from a fresh leadership approach to ensure Artrya's ongoing success as it pursues regulatory approvals in the United States, and business opportunities in the jurisdictions in which it has approval. Mr. Barrington will step down from the Board and resign as Managing Director on 27 March 2023, with Mr. Regan taking over as Chief Executive Officer from 27 March 2023.

Mr. Barrington will remain a significant shareholder in Artrya and continues to be a strong supporter of the Company.